[
    "{\"step_by_step_thinking\": \"Document [0] states that Estrogen receptor-\u03b1 (ER) is the key feature of most breast cancers and binding of ER to the genome correlates with expression of the Forkhead protein FOXA1. This suggests that estrogen, which binds to the estrogen receptor, could lead to the activation of FOXA1. Document [1] also mentions that the Forkhead protein FOXA1 is emerging as a key factor dictating global chromatin structure and the transcriptional function of ER in breast and non-breast cancer cells. This further supports the idea that estrogen could lead to the activation of FOXA1. Document [10] states that the vast majority of FOXA1 binding events are unaffected by steroid activation, which includes estrogen. However, this does not necessarily mean that estrogen does not lead to FOXA1 activation, it could simply mean that the binding of FOXA1 is not affected by the presence of estrogen. Therefore, based on the information provided, it seems that estrogen could potentially lead to the activation of FOXA1.\", \"answer_choice\": \"A\"}"
]